Abstract
Erythroid and megakaryocyte lineages are closely linked and may share a common bipotent progenitor. However, the mechanisms associated with cell lineage commitment are not fully understood. The K562 erythroleukemia cell line serves as a model to study the biochemical changes associated with erythroid and megakaryocyte (E/M) differentiation. We have previously established that PMA-induced megakaryocyte differentiation of K562 cells requires the activity of the MEK/MAPK pathway (Herrera et al Exp Cell Res 1998; 238: 407–414). Here, we show that the PMA-induced phenotypic changes of K562 cells such as polylobulation of the nucleus and Pyk2 expression are independent of MAPK activation. In addition, we also demonstrate that inhibition of the basal activity of the extracellular regulated kinase (ERK/MAPK) pathway enhances the erythroid phenotype of these cells. These results suggest that the MAPK pathway regulates the E/M lineage commitment of K562 cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shelly, C., Petruzzelli, L. & Herrera, R. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events. Leukemia 12, 1951–1961 (1998). https://doi.org/10.1038/sj.leu.2401221
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401221
Keywords
This article is cited by
-
Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
Annals of Hematology (2022)
-
Inhibition of red blood cell development by arsenic-induced disruption of GATA-1
Scientific Reports (2020)
-
SMARCAL1 Negatively Regulates C-Myc Transcription By Altering The Conformation Of The Promoter Region
Scientific Reports (2015)
-
Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells
Leukemia (2009)
-
The α1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells
Annals of Hematology (2009)